Stay updated on Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer

Sign up to get notified when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page

  1. Check
    yesterday
    Change Detected
    Summary
    The clinical trial record is displayed, including the study design, eligibility criteria, locations, outcome measures, publications, and data-sharing information for the completed ovarian cancer study.
    Difference
    100%
    Check dated 2026-11-13T15:28:15.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error rather than the study details.
    Difference
    0.2%
    Check dated 2026-10-30T15:57:34.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-23T15:59:09.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-16T16:00:40.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-09T16:12:36.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The study page now renders as a 403 Forbidden error, showing a minimal HTML page with a 403 message and a Home link instead of the usual study content. As a result, access to the study file and related materials is blocked, altering the page’s main function of presenting trial details.
    Difference
    17%
    Check dated 2026-09-25T18:31:51.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.